Q: 5 months since the last question on NURS. With their estimates for $150 million of revenue for 2026, and the recent financing, what is your current opinion?
5i Research Answer:
NURS is small ($221M market cap), but forward estimates are strong, and analysts' estimates have been trending higher. The $150M sales guidance for FY2026 is an impressive guide higher, against its FY2025 sales estimates of $35M. It has a history of inconsistent sales beats, where the latest earnings results showed a big miss on sales, and the earnings before that were also a substantial miss. We would be cautious here, given the substantial raise in guidance and history of not meeting expectations, but the company is growing, it has real operating leverage potential, and we would prefer to see management execute on guidance before getting more interested.